Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Seagate Technology Holdings PLC — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Seagate Technology Holdings PLC trades at $844 (market cap $185.97B). The key difference: Seagate Technology Holdings PLC is far larger — about 36.7× ACADIA Pharmaceuticals Inc.'s market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | STX | |
|---|---|---|
Market Cap | $5.07B | $185.97B |
Sector | Health | Technology |
52-Week High | $29.41 | $1.09K |
52-Week Low | $20.06 | $154.43 |
Enterprise Value | $4.19B | $188.12B |
Dividend Yield | — | 0.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
